Jamjoom Pharma plans to release Q2 2025 financials on July 24

15/07/2025 Argaam
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) said it plans to announce its financial results for the second quarter of 2025 before the trading session begins on the Saudi Exchange (Taawul) on Thursday, July 24.

 

In a statement to Tadawul, the company said it will host its earnings call on the same day at 3pm KSA time after the close of the trading session to discuss Q2 2025 results with investors and analysts.

 

For more news on listed companies

 

The presentation for the earnings call will be uploaded on the investor relations webpage on Jamjoom Pharma’s website.

 

According to data available with Argaam, analysts estimate Jamjoom Pharma's Q2 2025 average net profit at SAR 123.32 million.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.